Stock Analysis on Net

UnitedHealth Group Inc. (NYSE:UNH)

DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin 

Microsoft Excel

Two-Component Disaggregation of ROE

UnitedHealth Group Inc., decomposition of ROE

Microsoft Excel
ROE = ROA × Financial Leverage
Dec 31, 2025 12.81% = 3.89% × 3.29
Dec 31, 2024 15.55% = 4.83% × 3.22
Dec 31, 2023 25.22% = 8.18% × 3.08
Dec 31, 2022 25.87% = 8.19% × 3.16
Dec 31, 2021 24.09% = 8.15% × 2.96

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).


The period under review demonstrates fluctuating performance in key financial metrics. Return on Assets (ROA) exhibited initial stability followed by a notable decline, while Financial Leverage generally increased. Consequently, Return on Equity (ROE) mirrored these trends, initially rising before experiencing a significant decrease.

Return on Assets (ROA)
ROA remained relatively consistent between 2021 and 2023, fluctuating around 8.15% to 8.19%. However, a substantial decrease is observed in 2024, falling to 4.83%, and continuing downward to 3.89% in 2025. This suggests a diminishing ability to generate earnings from its asset base.
Financial Leverage
Financial Leverage showed a gradual increase from 2.96 in 2021 to 3.16 in 2022 and 3.08 in 2023. It then increased again to 3.22 in 2024 and further to 3.29 in 2025. This indicates an increasing reliance on debt financing.
Return on Equity (ROE)
ROE increased from 24.09% in 2021 to 25.87% in 2022, then slightly decreased to 25.22% in 2023. A significant decline is then apparent, with ROE falling to 15.55% in 2024 and further to 12.81% in 2025. This decrease aligns with the declining ROA, despite the increasing Financial Leverage.

The initial stability in ROE between 2021 and 2023 was maintained by a relatively consistent ROA, amplified by increasing Financial Leverage. However, the subsequent decline in ROA, despite continued increases in Financial Leverage, resulted in a marked reduction in ROE. This suggests that the increased use of debt is not effectively translating into higher returns for equity holders as asset profitability diminishes.

AI Ask an analyst for more


Three-Component Disaggregation of ROE

UnitedHealth Group Inc., decomposition of ROE

Microsoft Excel
ROE = Net Profit Margin × Asset Turnover × Financial Leverage
Dec 31, 2025 12.81% = 2.72% × 1.43 × 3.29
Dec 31, 2024 15.55% = 3.65% × 1.32 × 3.22
Dec 31, 2023 25.22% = 6.09% × 1.34 × 3.08
Dec 31, 2022 25.87% = 6.25% × 1.31 × 3.16
Dec 31, 2021 24.09% = 6.06% × 1.34 × 2.96

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).


The period under review demonstrates fluctuating performance across key financial ratios impacting overall Return on Equity (ROE). A notable decline in ROE is observed from 2023 through 2025, despite some offsetting movements in the underlying components. The analysis below details the trends in Net Profit Margin, Asset Turnover, and Financial Leverage, and their combined effect on ROE.

Net Profit Margin
Net Profit Margin exhibited a slight increase from 6.06% in 2021 to 6.25% in 2022, before stabilizing around 6.09% in 2023. However, a significant downward trend is apparent from 2023, with the margin decreasing to 3.65% in 2024 and further to 2.72% in 2025. This decline represents the most substantial negative driver of ROE reduction during the period.
Asset Turnover
Asset Turnover remained relatively stable between 2021 and 2023, fluctuating between 1.31 and 1.34. A slight decrease to 1.32 is noted in 2024, followed by an increase to 1.43 in 2025. This improvement in 2025 partially offsets the negative impact of the declining Net Profit Margin, indicating increased efficiency in asset utilization.
Financial Leverage
Financial Leverage generally increased over the period, rising from 2.96 in 2021 to 3.16 in 2022 and 3.08 in 2023. Further increases are observed in 2024 (3.22) and 2025 (3.29). While increased leverage typically amplifies ROE, its positive effect was insufficient to counteract the substantial decline in Net Profit Margin.
Return on Equity (ROE)
ROE increased from 24.09% in 2021 to 25.87% in 2022, and remained relatively high at 25.22% in 2023. However, a marked decrease is evident from 2023, with ROE falling to 15.55% in 2024 and 12.81% in 2025. This decline is primarily attributable to the significant reduction in Net Profit Margin, despite positive contributions from Asset Turnover and Financial Leverage in later years.

In summary, the observed trend in ROE is largely driven by the decreasing Net Profit Margin. While improvements in Asset Turnover and increases in Financial Leverage provide some mitigation, they are not enough to offset the impact of reduced profitability. Continued monitoring of the Net Profit Margin is crucial for understanding future ROE performance.

AI Ask an analyst for more


Five-Component Disaggregation of ROE

UnitedHealth Group Inc., decomposition of ROE

Microsoft Excel
ROE = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Financial Leverage
Dec 31, 2025 12.81% = 0.86 × 0.78 × 4.05% × 1.43 × 3.29
Dec 31, 2024 15.55% = 0.75 × 0.83 × 5.86% × 1.32 × 3.22
Dec 31, 2023 25.22% = 0.79 × 0.90 × 8.60% × 1.34 × 3.08
Dec 31, 2022 25.87% = 0.78 × 0.93 × 8.67% × 1.31 × 3.16
Dec 31, 2021 24.09% = 0.79 × 0.93 × 8.25% × 1.34 × 2.96

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).


The five-component DuPont analysis reveals shifts in the drivers of return on equity over the observed period. Return on Equity (ROE) initially increased from 2021 to 2022, then experienced a substantial decline through 2025. This fluctuation is attributable to changes in profitability, efficiency, and financial leverage.

Profitability (EBIT Margin)
The EBIT Margin demonstrated an initial improvement from 8.25% in 2021 to 8.67% in 2022, indicating enhanced operational efficiency. However, a significant downward trend commenced in 2023, culminating in a substantial decrease to 4.05% by 2025. This decline in profitability is a primary contributor to the overall reduction in ROE observed during the latter part of the period.
Efficiency (Asset Turnover)
Asset Turnover remained relatively stable between 2021 and 2023, fluctuating around 1.34. A slight increase was noted in 2024 (1.32), followed by a more pronounced increase to 1.43 in 2025. This suggests improving efficiency in asset utilization towards the end of the period, though this improvement was not sufficient to offset the decline in profitability.
Financial Leverage
Financial Leverage exhibited an increasing trend from 2.96 in 2021 to 3.29 in 2025. This indicates a growing reliance on debt financing. While increased leverage can amplify returns, it also magnifies risk. The increasing leverage contributed to the higher ROE in 2022, but its effect was overshadowed by the declining EBIT margin in subsequent years.
Tax Burden
The Tax Burden remained relatively consistent between 2021 and 2023, hovering around 0.79. A decrease to 0.75 was observed in 2024, followed by an increase to 0.86 in 2025. These fluctuations had a minor impact on ROE compared to the more substantial changes in profitability and leverage.
Interest Burden
The Interest Burden showed a gradual decline from 0.93 in 2021 and 2022 to 0.78 in 2025. This suggests a decreasing proportion of earnings allocated to interest expense, potentially due to debt restructuring or lower interest rates. However, this positive trend was insufficient to counteract the negative impact of the declining EBIT margin on overall ROE.

In summary, the decline in ROE from 2022 to 2025 is primarily driven by a significant reduction in the EBIT Margin. While improvements in asset turnover and a decreasing interest burden were observed, these were not enough to compensate for the diminished profitability. The increasing financial leverage amplified the impact of the lower EBIT margin, contributing to the substantial decrease in ROE.

AI Ask an analyst for more


Two-Component Disaggregation of ROA

UnitedHealth Group Inc., decomposition of ROA

Microsoft Excel
ROA = Net Profit Margin × Asset Turnover
Dec 31, 2025 3.89% = 2.72% × 1.43
Dec 31, 2024 4.83% = 3.65% × 1.32
Dec 31, 2023 8.18% = 6.09% × 1.34
Dec 31, 2022 8.19% = 6.25% × 1.31
Dec 31, 2021 8.15% = 6.06% × 1.34

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).


The financial performance, as indicated by the presented metrics, demonstrates a shift in profitability and efficiency over the five-year period. Return on Assets (ROA) initially remained stable before experiencing a notable decline. This shift is attributable to changes in both Net Profit Margin and Asset Turnover.

Net Profit Margin
The Net Profit Margin exhibited a slight increase from 6.06% in 2021 to 6.25% in 2022, followed by a marginal decrease to 6.09% in 2023. However, a significant downward trend is observed in 2024 and 2025, with the margin declining to 3.65% and 2.72% respectively. This suggests increasing cost pressures or decreasing revenue quality over time.
Asset Turnover
Asset Turnover remained relatively consistent between 2021 and 2023, fluctuating around 1.34. A slight decrease to 1.32 was noted in 2024, but a positive change is evident in 2025, with the ratio increasing to 1.43. This indicates improved efficiency in utilizing assets to generate revenue in the most recent year.
Return on Assets (ROA)
ROA remained stable at approximately 8.15% - 8.19% from 2021 to 2023. The decline in Net Profit Margin beginning in 2024 directly impacted ROA, causing it to fall to 4.83% in 2024 and further to 3.89% in 2025. While the increase in Asset Turnover in 2025 partially offset the impact of the declining profit margin, it was insufficient to maintain ROA at its earlier levels. The observed trend suggests that profitability is becoming a more significant driver of overall returns than asset efficiency.

In summary, the observed performance indicates a transition from a period of stable returns to one characterized by declining profitability, despite improvements in asset utilization in the final year. The substantial decrease in Net Profit Margin appears to be the primary factor driving the reduction in ROA.

AI Ask an analyst for more


Four-Component Disaggregation of ROA

UnitedHealth Group Inc., decomposition of ROA

Microsoft Excel
ROA = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover
Dec 31, 2025 3.89% = 0.86 × 0.78 × 4.05% × 1.43
Dec 31, 2024 4.83% = 0.75 × 0.83 × 5.86% × 1.32
Dec 31, 2023 8.18% = 0.79 × 0.90 × 8.60% × 1.34
Dec 31, 2022 8.19% = 0.78 × 0.93 × 8.67% × 1.31
Dec 31, 2021 8.15% = 0.79 × 0.93 × 8.25% × 1.34

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).


The four-component DuPont analysis reveals shifting dynamics in profitability and efficiency between 2021 and 2025. Overall, Return on Assets (ROA) experienced a notable decline, driven primarily by decreasing profitability margins, partially offset by improvements in asset utilization towards the end of the period.

Tax Burden
The tax burden remained relatively stable between 2021 and 2023, fluctuating around 0.79. A decrease to 0.75 was observed in 2024, followed by a substantial increase to 0.86 in 2025. This suggests a changing effective tax rate impacting net income.
Interest Burden
The interest burden demonstrated a consistent, albeit gradual, decline from 0.93 in 2021 and 2022 to 0.78 in 2025. This indicates improved capacity to cover interest expenses, potentially due to debt reduction or lower interest rates.
EBIT Margin
The EBIT margin initially increased from 8.25% in 2021 to 8.67% in 2022, before stabilizing at 8.60% in 2023. A significant decrease was then observed, falling to 5.86% in 2024 and further to 4.05% in 2025. This substantial decline in operating profitability is the primary driver of the overall ROA reduction.
Asset Turnover
Asset turnover remained relatively consistent between 2021 and 2023, fluctuating around 1.33. A slight decrease to 1.32 was noted in 2024, followed by a more pronounced increase to 1.43 in 2025. This suggests improving efficiency in utilizing assets to generate revenue towards the end of the analyzed period, partially mitigating the impact of declining profitability.
Return on Assets (ROA)
ROA exhibited a slight increase from 8.15% in 2021 to 8.19% in 2022, followed by stabilization at 8.18% in 2023. A substantial decline was then observed, with ROA falling to 4.83% in 2024 and further to 3.89% in 2025. This decline directly correlates with the decreasing EBIT margin, despite the improving asset turnover in the final year.

In summary, the decline in ROA is largely attributable to the significant reduction in the EBIT margin. While improvements in asset turnover offer some offset, they are insufficient to counteract the impact of reduced operating profitability. The changing tax burden also contributes to the overall trend, while the decreasing interest burden provides a positive, though limited, counterforce.

AI Ask an analyst for more


Disaggregation of Net Profit Margin

UnitedHealth Group Inc., decomposition of net profit margin ratio

Microsoft Excel
Net Profit Margin = Tax Burden × Interest Burden × EBIT Margin
Dec 31, 2025 2.72% = 0.86 × 0.78 × 4.05%
Dec 31, 2024 3.65% = 0.75 × 0.83 × 5.86%
Dec 31, 2023 6.09% = 0.79 × 0.90 × 8.60%
Dec 31, 2022 6.25% = 0.78 × 0.93 × 8.67%
Dec 31, 2021 6.06% = 0.79 × 0.93 × 8.25%

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).


An examination of the provided financial metrics reveals evolving profitability dynamics over the five-year period. The net profit margin demonstrates a clear declining trend, while the contributing factors of EBIT margin, tax burden, and interest burden exhibit varied movements. A disaggregation of the net profit margin suggests shifting influences on overall profitability.

Net Profit Margin
The net profit margin decreased consistently from 6.06% in 2021 to 2.72% in 2025. This represents a substantial contraction in profitability, indicating that a smaller proportion of revenue is translating into net income over time. The most significant decline occurred between 2023 and 2024, and then again between 2024 and 2025.
EBIT Margin
The EBIT margin initially increased from 8.25% in 2021 to 8.67% in 2022, before stabilizing at 8.60% in 2023. However, a marked decrease is observed in subsequent years, falling to 5.86% in 2024 and further to 4.05% in 2025. This suggests a weakening of core operational profitability, contributing significantly to the decline in the net profit margin.
Tax Burden
The tax burden remained relatively stable between 2021 and 2023, fluctuating around 0.79. A decrease to 0.75 is noted in 2024, followed by a substantial increase to 0.86 in 2025. This indicates a growing proportion of income allocated to taxes in the most recent year, partially offsetting profitability. The increase in tax burden in 2025 likely exacerbated the decline in net profit margin.
Interest Burden
The interest burden exhibited a consistent downward trend, decreasing from 0.93 in 2021 and 2022 to 0.90 in 2023, 0.83 in 2024, and finally to 0.78 in 2025. This suggests a decreasing proportion of income allocated to interest expenses, providing a partial offset to the declining EBIT margin and increasing tax burden. The reduction in interest burden represents a positive development, but was insufficient to counteract the other negative trends.

In summary, the decline in net profit margin appears primarily driven by the substantial reduction in the EBIT margin. While the decreasing interest burden provided some mitigation, it was outweighed by the combined effect of the declining EBIT margin and the increasing tax burden, particularly in the final year of the observed period.

AI Ask an analyst for more